Table 1 Clinicopathological characteristics in a total of 66 patients
Total (n = 66) | UEDVT | P-valuea | ||
|---|---|---|---|---|
Positive (n = 11) | Negative (n = 55) | |||
Age-year | ||||
Mean (range) | 63.2 (51–76) | 66.8 (41–83) | 0.18 | |
Gender (%) | ||||
Male | 51 | 10 (90.9) | 41 (74.5) | 0.43 |
Female | 15 | 1 (9.1) | 14 (25.5) | |
BMI | ||||
Mean (range) | 22.5 (18.67–27) | 20.9 (15–27.9) | 0.087 | |
Smoking history (%) | ||||
Yes | 11 (100) | 43 (78.2) | 0.087 | |
No | 0 (0) | 12 (21.8) | ||
Preoperative co morbidity (%) | ||||
Hypertension | 30 | 6 (54.6) | 24 (43.6) | 0.51 |
Diabetes mellitus | 7 | 0 (0) | 7 (12.7) | 0.21 |
Anti-coagulate drug | 2 | 0 (0) | 2 (3.64) | 0.52 |
Respiratory disorder | 8 | 0 (0) | 8 (14.6) | 0.18 |
Tumor location (%) | ||||
Ut | 10 | 3 (27.3) | 7 (12.7) | 0.93 |
Mt | 38 | 6 (54.5) | 32 (58.2) | |
Lt | 18 | 2 (18.2) | 16 (29.1) | |
pStage (%) | ||||
I | 4 (36.4) | 26 (47.3) | 0.187 | |
II | 4 (36.4) | 6 (10.9) | ||
III | 2 (18.2) | 18 (32.7) | ||
IV | 1 (9) | 5 (9.1) | ||
Neoadjuvant therapy (%) | ||||
Yes | 5 (45.5) | 35 (63.6) | 0.25 | |
No | 6 (54.5) | 20 (36.4) | ||
Operative approach (%) | ||||
Right transthoracic | 7 (63.6) | 24 (43.6) | 0.23 | |
Thoracoscopic | 4 (36.4) | 31 (56.4) | ||
Lymph node dissection (%) | ||||
3-field | 10 (90.9) | 45 (81.8) | 0.46 | |
2-field | 1 (9.1) | 10 (18.2) | ||
Operation time, median value (range) (min) | 494.9 | 482.9 (417–601) | 497.3 (355–732) | 0.60 |
Blood loss, median value (range) (ml) | 283.7 | 271 (60–905) | 286.2 (10–2710) | 0.76 |
Clavien–Dindo Grade | ||||
3b ≦ | 0 (0) | 3 (5.5) | 0.43 | |
3a ≧ | 11 (100) | 52 (94.6) | ||
R0 | 10 (90.9) | 49 (89.1) | 0.86 | |
R1/2 | 1 (9.1) | 6 (10.9) | ||